Navigation Links
NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welch's
Date:9/17/2007

HUBBARD, Ohio, Sept. 17 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX), a nano-biotechnology company, announced it has achieved a historical event with the first onsite generation of electricity using hydrogen gas produced from its bioreactor prototype facility at Welch Foods Inc., a Cooperative in Pennsylvania.

A 5.5 kW generator converted to run on hydrogen was utilized for the demonstration. The generator ran flawlessly on hydrogen gas produced by NanoLogix's hydrogen bioreactor system and powered multiple strings of 100- watt light bulbs. "To the best of our knowledge, this is the first time in history that electricity has been generated anywhere onsite using hydrogen produced through the use of bacteria to digest waste", said Harry Diz, Department Chair and Professor of Environmental Engineering at Gannon University and NanoLogix Bioreactor Development chief. Video: http://www.youtube.com/watch?v=cS_jmMwy9D8

Paul Zorzie, Welch's Engineering Manager, stated, "Welch's is happy to provide the site at which this groundbreaking research into generating alternative energy from waste is taking place. We look forward to the potential of building upon these developments to scale up and use this energy for our operation."

Bret Barnhizer, Chairman and CEO of NanoLogix, stated, "We are delighted at the results of the work by Professor Diz and associates and anticipate potential upscaling of the Welch's operation to commercial bioreactor status. The Welch's development, enabling conversion of sugar from their wastewater stream to produce hydrogen, has contributed immeasurably to ongoing research and development for processing other types of waste streams. Linked to that development and following our business plan for expansion, in the spring of 2008 we intend to begin bioreactor construction at the Erie Wastewater Treatment Plant for the extraction of hydrogen from their p
'/>"/>

SOURCE NanoLogix Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Freeslate, ... solutions, today announced that Lupin Limited, one of India’s ... CM Protégé PharmD System for high throughput ... India, is focused on a wide range of quality, ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Carahsoft and ... Thursday, January 23, 2014 at 2pm EST (11am PST), ... The topic focuses on how technology can turn raw, ... decisions for government agencies. The online webinar will last ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of strategic ... business, and media events in the United States ... associate Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of service ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Ltd. (NYSE Amex:, SVA ), a leading developer and provider of ... and twelve month,periods ended December 31, 2008. , , ... 2008 sales increasing 39% year-over-year to $46.5, ... in 2008, up from 5.12 million in, ...
... Calif., April 9 Jivan announced today ... high-throughput transcriptome sequencing (RNA-Seq) and expression. Leveraging ... mRNA in biological samples, Jivan will provide ... will offer content for targeted sequencing with ...
... expansion of PROVENT(R) Sleep Apnea Therapy in Limited ... Inc. a privately-held, medical device company, focused on ... the appointment of John McCutcheon as President and ... company also announced that current CEO Jeffrey Nugent ...
Cached Biology Technology:Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 13Jivan Focuses on Solutions for Transcriptome Sequencing 2Ventus Medical Appoints John McCutcheon as President and CEO 2
(Date:4/17/2014)... fish consumption advisories for expecting mothers are ineffective ... persistent organic pollutants (POPs). , The study, ... of Toronto Scarborough PhD student Matt Binnington and ... of environmental contamination, a mother,s compliance with advisories, ... influenced exposure in her children. , Their model ...
(Date:4/17/2014)... engineer has developed a patented technique that improves ... The same technique could help police during drug ... Kay L. Theede chair in engineering and department ... research team have created a template-based system that ... The distance detection method called stand-off bomb ...
(Date:4/17/2014)... honeybees in Europe, Asia and the United States are ... be impacting native honeybee populations at this time, according ... include including Nosema microsporidia and Varroa ... resilient to these invasive pests, which suggests to us ... Asia and the United States currently are not necessary ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Patented research remotely detects nitrogen-rich explosives 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... Harbor, N.Y. One way of regulating protein levels in ... These are intermediary molecules that are first copied from DNA ... then transported into the cell,s body to be translated into ... Spring Harbor Laboratory (CSHL) has now discovered that mRNAs can ...
... Without aggressive action to reduce soot emissions, the ... to be significantly accelerated in order to achieve international ... last December,s Copenhagen Accord, according to " Assessing the ... published online June 21 in the Proceedings of the ...
... the Danish Cancer Society and the Herlev University Hospital ... for multiple tumor markers in bladder cancer. The ... multiple short synthetic probes: application to methylation analysis of ... from patients with bladder cancer," appears in the July ...
Cached Biology News:Messenger RNAs are regulated in far more ways than previously appreciated, CSHL team finds 2Aggressive action to reduce soot emissions needed to meet climate change goals 2Aggressive action to reduce soot emissions needed to meet climate change goals 3New diagnostic test for bladder cancer 2
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048...
... [HDAC8-48] to HDAC8 Regulation of ... mechanisms such as DNA methylation, ATP-dependent ... of histones, which include the dynamic ... of lysine residues present in the ...
... 2-D Sample Preparation for Membrane Proteins ... process 25 membrane,protein extracts for 2-D gel ... Membrane Protein Extraction Kit , ... pellet,fractions with a packed cell weight of ...
...
Biology Products: